Laser-Assisted Lipolysis (SmartLipo, Cellulaze): FDA Clearances, Evidence, MAUDE
A comprehensive clinical and regulatory guide to interstitial laser-assisted lipolysis (SmartLipo) and laser cellulite subcision (Cellulaze), comparing them with VASER…
Fat reduction, muscle stimulation, skin tightening below the neck. What works, what's overpromised, and who isn't a candidate.
A comprehensive clinical and regulatory guide to interstitial laser-assisted lipolysis (SmartLipo) and laser cellulite subcision (Cellulaze), comparing them with VASER…
A technical and clinical comparison of SculpSure (1060nm contact) and EON (1064nm touchless robotic) laser lipolysis: FDA PKT clearances, delivery mechanisms, and MAUDE…
A clinical evaluation of lipotropic MIC-B12 injections, examining the evidence for weight-loss claims, metabolic pathways, and safety profiles from public database…
Semaglutide's key US patent runs to late 2031 and tirzepatide's to early 2036. We read the FDA Orange Book to show when generic GLP-1 weight-loss drugs can actually…
Nine original PMA applications, 400 total PMA records, and the 2024 entry of Motiva: what the FDA premarket-approval database reveals about who makes the breast implants…
347,618 FDA MAUDE reports on silicone and saline breast implants: rupture and capsular contracture dominate, BIA-ALCL reporting spiked with the 2019 Allergan recall, and…
An evidence map of cellulite from 62 clinical trials and the FDA record: Cellfina subcision lasts longest, RESONIC clears dimples in one session, and the Qwo injectable…
11,280 FDA MAUDE reports under cryolipolysis code OOK: 95.1% describe paradoxical adipose hyperplasia (PAH), reporting surged a thousand-fold from 2019 to 2023, and…
526 FDA MAUDE reports on liposuction devices show injuries and malfunctions split nearly even, VASER ultrasound systems dominate, and thermal burns are the signature…
Buccal fat removal (bichectomy) permanently reduces cheek fullness. A 2025 meta-analysis of 308 patients found a 25% complication rate, and the long-term aging question…